StockData
Fulgent Genetics, Inc. logo

Fulgent Genetics, Inc. (FLGT) stock

FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3047% below fair value
$24.21+0.14 (+0.56%)

Close on Nov 17, 2026Market cap $666.15MP/E –Yield –

Fulgent Genetics total assets

Total assets on the balance sheet at the end of each period.

Fulgent Genetics's total assets was $1.09B at Jun 30, 2026. For fiscal 2025 it was $1.21B, down 0.5% from the year before. Over ten years it grew 70.5% a year on average. The highest annual figure on record is $1.39B in fiscal 2022.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.21B-0.5%
FY2024Dec 31, 2024$1.22B-1.2%
FY2023Dec 31, 2023$1.24B-10.9%
FY2022Dec 31, 2022$1.39B+8.4%
FY2021Dec 31, 2021$1.28B+82.6%
FY2020Dec 31, 2020$700.46M+689.2%
FY2019Dec 31, 2019$88.76M+64.7%
FY2018Dec 31, 2018$53.90M-5.7%
FY2017Dec 31, 2017$57.18M-1.5%
FY2016Dec 31, 2016$58.04M+895.2%
FY2015Dec 31, 2015$5.83M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.09B-9.2%
Q1 FY2026Mar 31, 2026$1.16B-4.1%
Q4 FY2025Dec 31, 2025$1.21B-0.5%
Q3 FY2025Sep 30, 2025$1.21B-1.6%
Q2 FY2025Jun 30, 2025$1.20B-2.6%
Q1 FY2025Mar 31, 2025$1.21B-2.0%
Q4 FY2024Dec 31, 2024$1.22B-1.2%
Q3 FY2024Sep 30, 2024$1.23B-9.2%
Q2 FY2024Jun 30, 2024$1.23B-9.0%
Q1 FY2024Mar 31, 2024$1.23B-10.7%
Q4 FY2023Dec 31, 2023$1.24B-10.9%
Q3 FY2023Sep 30, 2023$1.36B-3.4%
Q2 FY2023Jun 30, 2023$1.35B-7.3%
Q1 FY2023Mar 31, 2023$1.38B-6.1%
Q4 FY2022Dec 31, 2022$1.39B+8.4%
Q3 FY2022Sep 30, 2022$1.41B+16.7%
Q2 FY2022Jun 30, 2022$1.46B+39.2%
Q1 FY2022Mar 31, 2022$1.47B+46.7%
Q4 FY2021Dec 31, 2021$1.28B+82.6%
Q3 FY2021Sep 30, 2021$1.20B+387.1%
Q2 FY2021Jun 30, 2021$1.05B+994.6%
Q1 FY2021Mar 31, 2021$999.08M+1018.5%
Q4 FY2020Dec 31, 2020$700.46M+689.2%
Q3 FY2020Sep 30, 2020$247.31M+304.5%
Q2 FY2020Jun 30, 2020$95.92M+70.0%
Q1 FY2020Mar 31, 2020$89.33M+60.5%
Q4 FY2019Dec 31, 2019$88.76M+64.7%
Q3 FY2019Sep 30, 2019$61.15M+11.5%
Q2 FY2019Jun 30, 2019$56.44M+1.6%
Q1 FY2019Mar 31, 2019$55.65M+0.4%
Q4 FY2018Dec 31, 2018$53.90M-5.7%
Q3 FY2018Sep 30, 2018$54.85M-6.5%
Q2 FY2018Jun 30, 2018$55.55M-5.5%
Q1 FY2018Mar 31, 2018$55.44M-5.7%
Q4 FY2017Dec 31, 2017$57.18M-1.5%
Q3 FY2017Sep 30, 2017$58.67M+157.8%
Q2 FY2017Jun 30, 2017$58.81M–
Q1 FY2017Mar 31, 2017$58.82M–
Q4 FY2016Dec 31, 2016$58.04M–
Q3 FY2016Sep 30, 2016$22.76M–

More Fulgent Genetics figures

See a number that looks wrong?